Steven Boonen

Active 1995–2015

189
Papers
45,429
Citations
119
h-index
189
i10-index

Citations

Citations per year for Steven Boonen1985: 1 citations1996: 3 citations1997: 6 citations1998: 19 citations1999: 16 citations2000: 27 citations2001: 44 citations2002: 59 citations2003: 57 citations2004: 69 citations2005: 66 citations2006: 122 citations2007: 135 citations2008: 294 citations2009: 300 citations2010: 393 citations2011: 411 citations2012: 487 citations2013: 532 citations2014: 602 citations2015: 538 citations2016: 526 citations2017: 436 citations2018: 386 citations2019: 1,158 citations2020: 1,262 citations2021: 961 citations2022: 767 citations2023: 459 citations2024: 725 citations2025: 368 citations2026: 6 citations1986–1995: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,802 citing papers, 20.1% of this breakdownUnited Kingdom: 1,241 citing papers, 8.9% of this breakdownItaly: 801 citing papers, 5.8% of this breakdownChina: 777 citing papers, 5.6% of this breakdownAustralia: 668 citing papers, 4.8% of this breakdownBelgium: 617 citing papers, 4.4% of this breakdownCanada: 593 citing papers, 4.3% of this breakdownGermany: 576 citing papers, 4.1% of this breakdownNetherlands: 480 citing papers, 3.4% of this breakdownSpain: 453 citing papers, 3.3% of this breakdownFrance: 443 citing papers, 3.2% of this breakdownSwitzerland: 433 citing papers, 3.1% of this breakdown
0%20.1%Other 29%

Fields

  • Medicine82.1%
  • Biochemistry, Genetics and Molecular Biology10.5%
  • Engineering1.6%
  • Health Professions1.6%
  • Neuroscience0.7%
  • Dentistry0.5%
  • Other3%

Topics

  • Bone health and osteoporosis research13.4%
  • Bone health and treatments6%
  • Bone Metabolism and Diseases4.9%
  • Hip and Femur Fractures4.5%
  • Nutrition and Health in Aging3.5%
  • Hormonal and reproductive studies3.5%
  • Other64.2%

Coauthors

All papers

Open in search
  1. Romosozumab in Postmenopausal Women with Low Bone Mineral Density

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 1,235

  2. Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 2,955

  3. Zoledronic Acid and Clinical Fractures and Mortality after Hip Fracture

    Authors: , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2007 cited by 1,995

  4. Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men

    Authors: , , , , , , - Annals of Internal Medicine 2010 cited by 1,375

  5. Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2010 cited by 1,522

  6. Hypothalamic-Pituitary-Testicular Axis Disruptions in Older Men Are Differentially Linked to Age and Modifiable Risk Factors: The European Male Aging Study

    Authors: , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2008 cited by 922

  7. Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW

    Authors: , , , , , , , , , , , , , , , , , , , , - The American Journal of Medicine 2011 cited by 551

  8. Age-Related Changes in General and Sexual Health in Middle-Aged and Older Men: Results from the European Male Ageing Study (EMAS)

    Authors: , , , , , , , , , , , , , , , , , , , , - The Journal of Sexual Medicine 2009 cited by 536

  9. Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis

    Authors: , , , , , , , - New England Journal of Medicine 2007 cited by 908

  10. The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

    Authors: , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2011 cited by 695

  11. Characteristics of Secondary, Primary, and Compensated Hypogonadism in Aging Men: Evidence from the European Male Ageing Study

    Authors: , , , , , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2010 cited by 599

  12. Effects of denosumab on fracture and bone mineral density by level of kidney function

    Authors: , , , , , , , , , , , - Journal of Bone and Mineral Research 2011 cited by 352

  13. Fracture Risk and Zoledronic Acid Therapy in Men with Osteoporosis

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 359

  14. Effects of intravenous zoledronic acid plus subcutaneous teriparatide [rhPTH(1–34)] in postmenopausal osteoporosis

    Authors: , , , , , , , , , , , - Journal of Bone and Mineral Research 2010 cited by 359

  15. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial

    Authors: , , , , , , , , , - The Lancet 2009 cited by 837

  16. IOF position statement: vitamin D recommendations for older adults

    Authors: , , , , , , , , , - Osteoporosis International 2010 cited by 747

  17. Age-associated changes in hypothalamic–pituitary–testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study

    Authors: , , , , , , , , , , , , , , , , , , , , _ _ - European Journal of Endocrinology 2013 cited by 387

  18. Interspecies Differences in Bone Composition, Density, and Quality: Potential Implications for in Vivo Bone Research*

    Authors: , , , - Endocrinology 1998 cited by 753

  19. Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven Boonen, Dorota Włoch-Kopeć, Valerie Valant, Julia Slark, Karen L. Furie, Hossein Delavaran, Cordelia Langford, Panos Deloukas, Sarah Edkins, Sarah Hunt, Emma Gray, Serge Dronov, Leena Peltonen, Sólveig Grétarsdóttir, Gudmar Thorleifsson, Unnur Þorsteinsdóttir, Kāri Stefánsson, Giorgio B. Boncoraglio, Eugenio Parati, John Attia, Elizabeth Holliday, Christopher Levi, Maria-Grazia Franzosi, Anuj Goel, Anna Helgadóttir, Jenefer M. Blackwell, Elvira Bramon, Matthew A. Brown, Juan P. Casas, Aiden Corvin, Audrey Duncanson, Janusz Jankowski, Christopher G. Mathew, Colin N A Palmer, Robert Plomin, Anna Rautanen, Stephen Sawcer, Richard C. Trembath, Ananth C. Viswanathan, Nicholas Wood, Bradford B. Worrall, Steven J. Kittner, Braxton D. Mitchell, Brett Kissela, James F. Meschia, Vincent Thijs, Arne Lindgren, Mary Joan MacLeod, Agnieszka Słowik, James Walters, Jonathan Rosand, Pankaj Sharma, Martin Farrall, Cathie Sudlow, Peter M. Rothwell, Martin Dichgans, Peter Donnelly, Hugh S. Markus - Nature Genetics 2012 cited by 420

  20. Quality of Life in Sarcopenia and Frailty

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Calcified Tissue International 2013 cited by 409

  21. Impact of nutrition on muscle mass, strength, and performance in older adults

    Authors: , , , , , , , , , , , , , , - Osteoporosis International 2012 cited by 304

  22. Androgens and Bone

    Authors: , , , , , - Endocrine Reviews 2004 cited by 717

  23. Relationship of Weight, Height, and Body Mass Index With Fracture Risk at Different Sites in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2013 cited by 267

  24. Adverse Reactions and Drug–Drug Interactions in the Management of Women with Postmenopausal Osteoporosis

    Authors: , , , , , , , , - Calcified Tissue International 2011 cited by 208